31.9 F
New York
Friday, December 2, 2022

Date:

Share:

Meet AstraZeneca, Johnson & Johnson, Eli Lily and More at the 14th Annual RNA Therapeutics Conference 2023

Related Articles

Ramsey Asmar, MD Joins New York Cancer & Blood Specialists

Brooklyn, NY, December 01, 2022 --(PR.com)-- New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, is proud to announce the...

UserWise, LLC Launches Its First eLearning Catalog

San Jose, CA, December 01, 2022 --(PR.com)-- UserWise, LLC, a San Jose, California-based Human Factors consultancy for medical products, has launched its first catalog of...
London, United Kingdom, November 24, 2022 –(PR.com)– RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%.

In 2023, we will see the return of SAE Media Group’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field.

The two-day agenda offers peer-to-peer networking with Directors of novel RNA therapies, CEOs, Senior and expert scientists, Chief Medical Officers, Senior Vice Presidents and many more.

Visit the website at: http://www.therapeutics-rna.com/PR2prcom to download the brochure and view the full conference agenda

Register soon and take advantage…

Read more…

Popular Articles